In vitro experimental results demonstrated that farrerol could inhibit the proliferation and migration of CRC cells, induce cell cycle arrest at the G0/G1 phase, and suppress the protein expression of VEGFA, VEGFR2, and p-VEGFR2. This evidence concerns the gene VEGFA and colorectal carcinoma.